GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (XSWX:IDIA) » Definitions » Other Long Term Assets

Idorsia (XSWX:IDIA) Other Long Term Assets : CHF26.9 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Idorsia Other Long Term Assets?

Idorsia's other long-term assets for the quarter that ended in Mar. 2025 was CHF26.9 Mil.

Idorsia's quarterly other long-term assets declined from Sep. 2024 (CHF18.3 Mil) to Dec. 2024 (CHF10.0 Mil) but then increased from Dec. 2024 (CHF10.0 Mil) to Mar. 2025 (CHF26.9 Mil).

Idorsia's annual other long-term assets declined from Dec. 2022 (CHF47.5 Mil) to Dec. 2023 (CHF10.4 Mil) and declined from Dec. 2023 (CHF10.4 Mil) to Dec. 2024 (CHF10.0 Mil).


Idorsia Other Long Term Assets Historical Data

The historical data trend for Idorsia's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia Other Long Term Assets Chart

Idorsia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only 203.93 175.93 47.52 10.45 10.02

Idorsia Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.83 20.63 18.35 10.02 26.93

Idorsia Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Idorsia Business Description

Traded in Other Exchanges
Address
Hegenheimermattweg 91, Allschwil, CHE, 4123
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.

Idorsia Headlines

No Headlines